bioMerieux SA (BIM) - Financial and Strategic SWOT Analysis Review

June 2021 | 66 pages | ID: B7AB2413B37EN
GlobalData

Abstracts

bioMerieux SA (BIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

bioMerieux SA (bioMerieux), a subsidiary of Institut Merieux SA, develops, manufactures, and markets in vitro diagnostic solutions for hospital and private laboratories. The company offers diagnostic solutions such as systems, reagents, and software for the diagnosis of infectious diseases, cardiovascular diseases, and cancers and identifying microorganisms in pharmaceuticals, cosmetics, and agri-food products. It offers microbiology products, immunoassays, molecular biology tests, and other solutions for clinical applications and industrial microbiological control solutions for the food, biopharmaceutical, and cosmetics industries; veterinary diagnostic laboratories; and blood banks. bioMerieux also provides solutions for the enumeration of bacterial flora which indicate the quality of food products. The company distributes its products directly and through a network of distributors across the world. bioMerieux is headquartered in Marcy l’Etoile, France.

bioMerieux SA Key Recent Developments

Feb 24,2021: bioMerieux – 2020 financial results
Dec 14,2020: BioMerieux – Increased outlook for full-year 2020
Oct 22,2020: bioM?rieux – third-quarter 2020 business review
Oct 08,2020: AMSP partners with bioM?rieux to facilitate supply of high-quality COVID-19 diagnostics
Sep 30,2020: Johnson & Johnson joins other companies in signing a landmark Communiqu? on expanded global access for COVID-19

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

bioMerieux SA - Key Facts
bioMerieux SA - Key Employees
bioMerieux SA - Key Employee Biographies
bioMerieux SA - Major Products and Services
bioMerieux SA - History
bioMerieux SA - Company Statement
bioMerieux SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
bioMerieux SA - Business Description
Business Segment: Clinical Applications
Overview
Performance
Business Segment: Industrial Applications
Overview
Performance
Geographical Segment: Americas
Performance
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: Europe, Middle East, and Africa
Performance
R&D Overview
bioMerieux SA - Corporate Strategy
bioMerieux SA - SWOT Analysis
SWOT Analysis - Overview
bioMerieux SA - Strengths
bioMerieux SA - Weaknesses
bioMerieux SA - Opportunities
bioMerieux SA - Threats
bioMerieux SA - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

bioMerieux SA, Medical Equipment, Deals By Year, 2015 to YTD 2021
bioMerieux SA, Medical Equipment, Deals By Type, 2015 to YTD 2021
bioMerieux SA, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 24, 2021: bioMerieux – 2020 financial results
Dec 14, 2020: BioMerieux – Increased outlook for full-year 2020
Oct 22, 2020: bioM?rieux – third-quarter 2020 business review
Oct 08, 2020: AMSP partners with bioM?rieux to facilitate supply of high-quality COVID-19 diagnostics
Sep 30, 2020: Johnson & Johnson joins other companies in signing a landmark Communiqu? on expanded global access for COVID-19
Jul 09, 2020: bioM?rieux – Second quarter 2020 business performance preannouncement
Jun 02, 2020: Teklynx labeling software teklynx central increases labeling accuracy & compliance by 100% for global biotechnology company bioMerieux
Apr 16, 2020: bioM?rieux first-quarter 2020 business review
Mar 27, 2020: Novartis partners with life sciences companies to fight Covid-19
Mar 26, 2020: Novartis and life sciences companies commit expertise and assets to the fight against COVID-19 pandemic alongside Bill & Melinda Gates Foundation

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

bioMerieux SA, Key Facts
bioMerieux SA, Key Employees
bioMerieux SA, Key Employee Biographies
bioMerieux SA, Major Products and Services
bioMerieux SA, History
bioMerieux SA, Subsidiaries
bioMerieux SA, Key Competitors
bioMerieux SA, Ratios based on current share price
bioMerieux SA, Annual Ratios
bioMerieux SA, Annual Ratios (Cont...1)
bioMerieux SA, Annual Ratios (Cont...2)
bioMerieux SA, Interim Ratios
bioMerieux SA, Medical Equipment, Deals By Year, 2015 to YTD 2021
bioMerieux SA, Medical Equipment, Deals By Type, 2015 to YTD 2021
bioMerieux SA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

bioMerieux SA, Performance Chart (2016 - 2020)
bioMerieux SA, Ratio Charts
bioMerieux SA, Medical Equipment, Deals By Year, 2015 to YTD 2021
bioMerieux SA, Medical Equipment, Deals by Type, 2015 to YTD 2021